Article
Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond
10 Jan 2017
Abstract excerpt
The use of recombinant adeno-associated viruses (rAAVs) ushered in a new millennium of gene transfer for therapeutic treatment of a number of conditions, including congenital blindness, hemophilia, and spinal muscular atrophy. rAAV vectors have remarkable staying power from a therapeutic standpoint, withstanding several ebbs and flows. As new technologies such as clustered regularly interspaced short palindromic...
Topics
Join the communities discussing this publication.